Use of changes in serum alkaline phosphatase to predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy: A retrospective analysis of the TAX327 trial.
Publication
, Journal Article
Pond, GR; Sonpavde, G; Berry, WR; De Wit, R; Armstrong, AJ; Eisenberger, MA; Tannock, I
Published in: Journal of Clinical Oncology
May 20, 2010
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2010
Volume
28
Issue
15_suppl
Start / End Page
4637 / 4637
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Pond, G. R., Sonpavde, G., Berry, W. R., De Wit, R., Armstrong, A. J., Eisenberger, M. A., & Tannock, I. (2010). Use of changes in serum alkaline phosphatase to predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy: A retrospective analysis of the TAX327 trial. Journal of Clinical Oncology, 28(15_suppl), 4637–4637. https://doi.org/10.1200/jco.2010.28.15_suppl.4637
Pond, G. R., G. Sonpavde, W. R. Berry, R. De Wit, A. J. Armstrong, M. A. Eisenberger, and I. Tannock. “Use of changes in serum alkaline phosphatase to predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy: A retrospective analysis of the TAX327 trial.” Journal of Clinical Oncology 28, no. 15_suppl (May 20, 2010): 4637–4637. https://doi.org/10.1200/jco.2010.28.15_suppl.4637.
Pond GR, Sonpavde G, Berry WR, De Wit R, Armstrong AJ, Eisenberger MA, et al. Use of changes in serum alkaline phosphatase to predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy: A retrospective analysis of the TAX327 trial. Journal of Clinical Oncology. 2010 May 20;28(15_suppl):4637–4637.
Pond, G. R., et al. “Use of changes in serum alkaline phosphatase to predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy: A retrospective analysis of the TAX327 trial.” Journal of Clinical Oncology, vol. 28, no. 15_suppl, American Society of Clinical Oncology (ASCO), May 2010, pp. 4637–4637. Crossref, doi:10.1200/jco.2010.28.15_suppl.4637.
Pond GR, Sonpavde G, Berry WR, De Wit R, Armstrong AJ, Eisenberger MA, Tannock I. Use of changes in serum alkaline phosphatase to predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy: A retrospective analysis of the TAX327 trial. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010 May 20;28(15_suppl):4637–4637.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2010
Volume
28
Issue
15_suppl
Start / End Page
4637 / 4637
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences